Pentwater Capital Management »

Mirati Therapeutics shares owned by Pentwater Capital Management

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Pentwater Capital Management from 13F filings

Historical chart of Pentwater Capital Management investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Pentwater Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Pentwater Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $53M 903k 58.75

More positions owned by Pentwater Capital Management

Pioneer Natural Resources (PXD)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Hess Put Option (HES)
stock Put Option
United States Steel Corporation Put Option (X)
Karuna Therapeutics Ord Put Option
Capri Holdings SHS Put Option (CPRI)
Boeing Company Call Option (BA)
Chevron Corporation Call Option (CVX)
Endeavor Group Hldgs Cl A Com Call Option (EDR)
ImmunoGen Put Option
Kenvue Put Option (KVUE)
Teck Resources CL B Put Option (TECK)
Exxon Mobil Corporation Call Option (XOM)
Manchester Utd Ord Cl A Put Option (MANU)

View all positions for Pentwater Capital Management

Top funds holding Mirati Therapeutics

EcoR1 Capital
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Alpine Associates Management
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein

View all funds holding Mirati Therapeutics